FRPT Q4 2025

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025

Earnings

Freshpet delivered a standout fourth quarter, posting earnings per share of $0.64 against a consensus estimate of $0.41, a beat of 54.40%, even as revenue of $285.23 million came in just 0.21% shy of the $285.82 million Wall Street had expected. The … Read more Freshpet delivered a standout fourth quarter, posting earnings per share of $0.64 against a consensus estimate of $0.41, a beat of 54.40%, even as revenue of $285.23 million came in just 0.21% shy of the $285.82 million Wall Street had expected. The top line still grew 8.6% year-over-year, driven by volume gains of 9.7%, and capped a fiscal year in which Freshpet crossed the $1.10 billion annual net sales threshold for the first time. The profitability story was the real headline: GAAP gross margin expanded to 43.3% from 42.5% a year earlier, while SG&A costs fell sharply to 27.7% of net sales from 35.1%, reflecting reduced share-based compensation and lower variable compensation accruals. The company also hit positive free cash flow of $12.38 million for the full year, a milestone it had not expected to reach until 2026. Shares climbed roughly 5% on the news, though some observers noted the 2026 net sales growth guidance of 7% to 10%, alongside Adjusted EBITDA of $205 million to $215 million, signals a deliberate pivot toward execution and margin expansion over pure revenue acceleration.